Sinovac media relations director Pearson Liu said the agreement was only for Boryung to represent Sinovac. He denied the figure of 10 million doses, which would account for almost half of Sinovac's annual production.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.
Sinovac Biotech Ltd. is a holding company that conducts its business in China, through its 71.56%-owned subsidiary, Sinovac Beijing, and its wholly owned subsidiaries, Tangshan Yian and Sinovac Hong Kong. It is an integrated biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. The Company’s portfolio of products consists of vaccines against the hepatitis A, hepatitis B and influenza viruses. Its Panflu vaccine is available in China against the H5N1 influenza virus. Its pipeline consists of vaccine candidates in the pre-clinical and clinical development phases in China, including human vaccines for the EV71, Japanese encephalitis and rabies in pre-clinical development, a vaccine for the severe acute respiratory syndrome (SARS) virus that has completed a Phase I clinical trial and a split viron vaccine for the H5N1 influenza virus that has completed a Phase II clinical trial.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
Disclaimer: Full disclaimer at http://StockEinsteain.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinsteain, nor any of its affiliates are registered investment advisors or broker dealers.
Thank you for your interest in Findit News. A member of the Findit News team will contact you soon to show you how you can take your marketing to the next level with press releases on Findit.
